Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/21/23 17:00 | 12/18/23 | TCRX | Health | BioPrd | Biological Products, (No Diag | Barberich Timothy J | MA | D | P.m | 142 | 4.89 | 0 | 29 | 41 | 100 | D | |||||||||||||||
12/18/23 18:01 | 12/14/23 | TCRX | Health | BioPrd | Biological Products, (No Diag | Klencke Barbara | MA | D | P | 25 | 5.08 | 0 | 5 | 10 | 55 | D | |||||||||||||||
6/6/23 19:53 | 6/2/23 | TCRX | Health | BioPrd | Biological Products, (No Diag | Barberich Timothy J | MA | D | P | 100 | 2.63 | 0 | 38 | 114 | 71 | D | |||||||||||||||
12/29/22 14:34 | 12/27/22 | TCRX | Health | BioPrd | Biological Products, (No Diag | Silver Brian M. | MA | O | CFO | P.m | 9 | 1.54 | 0 | 6 | 22 | 33 | D | ||||||||||||||
5/20/22 16:15 | 5/18/22 | TCRX | Health | BioPrd | Biological Products, (No Diag | Southwell David P | MA | DO | CEO | P | 90 | 3.59 | 0 | 25 | 17 | 172 | D | ||||||||||||||
5/12/22 16:41 | 5/10/22 | TCRX | Health | BioPrd | Biological Products, (No Diag | Baker Bros. Advisors LP | NY | DT | P.m | 2,559 | 1.88 | 0 | 1,360 | 116 | 2,529 | I | |||||||||||||||
3/28/22 16:31 | 3/24/22 | TCRX | Health | BioPrd | Biological Products, (No Diag | Silver Brian M. | MA | O | CFO | P | 51 | 3.40 | 0 | 15 | 126 | 27 | D | ||||||||||||||
9/27/21 17:22 | 9/23/21 | TCRX | Health | BioPrd | Biological Products, (No Diag | Zdraveski Zoran | MA | O | GC | P | 35 | 7.48 | 0 | 5 | New | 5 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |